Merck & Co Subsidiaries and Acquisitions

  • October 22, 2024

Merck & Co has expanded into various industries through strategic acquisitions and the creation of subsidiaries. These strategic moves have strengthened Merck’s products and services, helping the company stay at the forefront of innovation while adapting to the changing needs of its customers. By integrating advanced technologies and expertise, Merck has enhanced its capabilities in pharmaceuticals, biotechnology, and healthcare solutions, allowing it to remain competitive in the global market.

How many companies were acquired by Merck & Co?

Merck & Co has acquired multiple companies, including significant players in the pharmaceutical and biotech sectors, to diversify its operations. These acquisitions have increased its presence in healthcare, life sciences, and advanced therapies, boosting its global influence and market reach.

Some notable acquisitions of

1. Prometheus Biosciences (Apr 16, 2023) – Specializes in precision medicine for immune-mediated diseases, with a focus on inflammatory bowel disease (IBD).

2. Acceleron Pharma (Sep 30, 2021) – Focuses on therapies for rare diseases and pulmonary arterial hypertension, particularly targeting the TGF-beta superfamily of proteins.

3. VelosBio (Nov 05, 2020) – Develops cancer therapies targeting receptor tyrosine kinase-like orphan receptor 1 (ROR1) for hematologic cancers and solid tumors.

4. Cubist Pharmaceuticals (Dec 08, 2014) – Known for developing antibiotics to treat serious bacterial infections, especially hospital-acquired and drug-resistant infections.

5. Idenix Pharmaceuticals (Jun 09, 2014) – Focuses on antiviral drugs, specifically treatments for hepatitis C virus (HCV).

List of Merck & Co Acquisitions

S. No.Acquiree NamePriceAnnounced Date
1Eyebiotech$3BMay 29, 2024
2Abceutics$208MApr 05, 2024
3Harpoon Therapeutics–Jan 08, 2024
4Caraway Therapeutics–Nov 20, 2023
5Prometheus Biosciences$10.8BApr 16, 2023
6Imago BioSciences$1.4BNov 21, 2022
7Acceleron Pharma$11.5BSep 30, 2021
8Pandion Therapeutics$1.9BFeb 25, 2021
9OncoImmune$425MNov 23, 2020
10VelosBio$2.8BNov 05, 2020
11Themis Bioscience–May 26, 2020
12StayWell Company–Mar 10, 2020
13ArQule$2.7BDec 09, 2019
14Calporta Therapeutics$576MNov 13, 2019
15Tilos Therapeutics$773MJun 10, 2019
16Peloton Therapeutics–May 21, 2019
17ConnectMed–Apr 05, 2019
18Immune Design$300MFeb 21, 2019
19Antelliq$2.1BDec 14, 2018
20Viralytics$502MFeb 21, 2018
21Rigontec$465MSep 06, 2017
22Afferent Pharmaceuticals$1.3BJun 09, 2016
23IOmet Pharma–Jan 13, 2016
24cCAM Biotherapeutics$95MJul 28, 2015
25OncoEthix$375MDec 18, 2014
26Cubist Pharmaceuticals$8.4BDec 08, 2014
27Preventice–Sep 12, 2014
28Peer+–Jun 30, 2014
29Idenix Pharmaceuticals$3.9BJun 09, 2014
30Inspire Pharmaceuticals$430MApr 05, 2011
31SmartCells$500MDec 02, 2010
32Frosst Iberica–Mar 26, 2010
33Schering-Plough–Jan 01, 2009
34NovaCardia$366.4MJul 25, 2007
35Abmaxis Inc$80MNov 09, 2006
36Sirna Therapeutics$1.1BOct 30, 2006
37GlycoFi Inc$400MMay 09, 2006
38Medco Containment Services Inc$6MNov 19, 1993

List of Merck & Co Subsidiaries

The table contains the 100 subsidiaries of Merck & Co –

S. No.CompanyCountry
1Abmaxis IncUnited States
2Acceleron Pharma IncUnited States
3Antelliq Finance IncUnited States
4Arqule IncUnited States
5Calporta Therapeutics IncUnited States
6Canji IncUnited States
7Caraway Therapeutics IncUnited States
8Glycofi IncUnited States
9Hawk And Falcon LlcUnited States
10Immune Design CorpUnited States
11Intervet IncUnited States
12Merck And Company LlcUnited States
13Merck Teknika LlcUnited States
14Mrl San Francisco LlcUnited States
15Mrl Ventures Fund LlcUnited States
16Oncoimmune IncUnited States
17Pandion Operations IncUnited States
18Rosetta Inpharmatics LlcUnited States
19Smartcells IncUnited States
20Themis Bio Holdings LlcUnited States
21Tilos Therapeutics IncUnited States
22Velosbio IncUnited States
23Vence CorpUnited States
24Vetinvent LlcUnited States
25Digital Angel SaArgentina
26Elastec SrlArgentina
27Intervet Argentina SaArgentina
28Allflex Australia Pty LtdAustralia
29Viralytics LimitedAustralia
30Intervet GesmbhAustria
31Merko Acquisition SaBelgium
32Merko NvBelgium
33Msd Animal Health BvBelgium
34Sol LimitedBermuda
35Corporation Allflex UlcCanada
36Intervet Canada CorpCanada
37Merck Canada IncCanada
38Velosbio Canada IncCanada
39Msd Danmark ApsDenmark
40Msd Egypt LlcEgypt
41Vetrex Egypt LlcEgypt
42Msd Finland OyFinland
43Allflex Europe SasFrance
44Diosynth France SasFrance
45Financiere MsdFrance
46Intervet SasFrance
47Msd FranceFrance
48Schering-Plough SasFrance
49Agrident GmbhGermany
50Burgwedel Biotech GmbhGermany
51Hydrochemie GmbhGermany
52Msd Pharma GmbhGermany
53Msd Verwaltungs GmbhGermany
54Rigontec GmbhGermany
55Intervet Hellas AeGreece
56Vaki Fiskeldiskerfi EhfIceland
57Pt Intervet IndonesiaIndonesia
58Identigen LimitedIreland
59Ccam Biotherapeutics LtdIsrael
60Msd Italia SrlItaly
61Opivi SrlItaly
62Vree Health Italia SrlItaly
63Msd Japan Holdings GkJapan
64Nihon Msd GkJapan
65Msd Korea Co LtdKorea
66Msd Luxembourg SarlLuxembourg
67Allflex Maroc SarlMorocco
68Intervet Maroc SaMorocco
69Agro Verhen BvNetherlands
70Cosmas BvNetherlands
71Diosynth Holding BvNetherlands
72Imago Biosciences BvNetherlands
73Intervet Agencies BvNetherlands
74Intervet Holding BvNetherlands
75Intervet International BvNetherlands
76Merck Sharp & Dohme BvNetherlands
77Merko Dalton BvNetherlands
78Msd Agencies BvNetherlands
79Msd Participations BvNetherlands
80Obs Holdings BvNetherlands
81Organon China BvNetherlands
82Theriak BvNetherlands
83Vetrex BvNetherlands
84Essex Pharmaceuticals IncPhilippines
85Msd Polska SpzooPoland
86Intervet Romania SrlRomania
87Sc Allflex Romania SrlRomania
88Msd Asia Holdings Pte LtdSingapore
89Laboratorios Abello SaSpain
90Idenix GmbhSwitzerland
91Identigen Switzerland AgSwitzerland
92Multilan AgSwitzerland
93Oncoethix GmbhSwitzerland
94Venco Holding GmbhSwitzerland
95Allflex Uk Group LimitedUnited Kingdom
96Msd LimitedUnited Kingdom
97Msd Vaccines LimitedUnited Kingdom
98Sureflap LimitedUnited Kingdom
99Iomet Pharma LimitedUnited Kingdom
100Msd Hh Vietnam LtdVietnam

Table of Content

Insights you may find interesting

Related Articles

Philip Morris Subsidiaries and Acquisitions

Philip Morris has expanded its presence across diverse industries, including tobacco, healthcare, and technology, through strategic acquisitions and subsidiaries. These acquisitions have not only diversified its product portfolio but also strengthened its ability to innovate and adapt to changing market trends. This strategic growth positions the company to remain competitive

Read More »

Raytheon Subsidiaries & Acquisitions

Raytheon has expanded its reach across multiple industries through key subsidiaries and acquisitions. By acquiring companies in cybersecurity, missile technology, and intelligence services, Raytheon has strengthened its expertise and entered new markets. These moves have enhanced its capabilities and positioned the company as a leader in both defense and commercial

Read More »

Colgate Palmolive Subsidiaries and Acquisitions

Colgate-Palmolive has grown across different industries through acquisitions and subsidiaries, helping the company improve its products and services. These acquisitions have strengthened its presence in areas like oral care, personal care, and pet nutrition, while also driving innovation. By bringing in new technology and expertise, Colgate-Palmolive continues to meet the

Read More »
Topics:

Was this article helpful?

Yes No

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.